New technology also can be used to turn off peanut and other food allergies
In an entirely new approach to treating asthma and allergies, a biodegradable nanoparticle acts like a Trojan horse, hiding an allergen in a friendly shell, to convince the immune system not to attack it, according to new Northwestern Medicine research. As a result, the allergic reaction in the airways is shut down long- term and an asthma attack prevented.
The technology can be applied to food allergies as well. The nanoparticle is currently being tested in a mouse model of peanut allergy, similar to food allergy in humans.
“The findings represent a novel, safe and effective long-term way to treat and potentially ‘cure’ patients with life-threatening respiratory and food allergies,” said senior author Stephen Miller, the Judy Gugenheim Research Professor of Microbiology-Immunology at Northwestern University Feinberg School of Medicine. “This may eliminate the need for life-long use of medications to treat lung allergy.”
It’s the first time this method for creating tolerance in the immune system has been used in allergic diseases. The approach has been used in autoimmune diseases including multiple sclerosis and celiac disease in previous preclinical Northwestern research.
The asthma allergy study was in mice, but the technology is progressing to clinical trials in autoimmune disease. The nanoparticle technology is being developed commercially by Cour Pharmaceuticals Development Co., which is working with Miller to bring this new approach to patients. A clinical trial using the nanoparticles to treat celiac disease is in development.
The new study on nanoparticles treating asthma was published April 18 in the Proceedings of the National Academy of Sciences.
“It’s a universal treatment,” Miller said. “Depending on what allergy you want to eliminate, you can load up the nanoparticle with ragweed pollen or a peanut protein.”
The nanoparticles are composed of an FDA-approved biopolymer called PLGA that includes lactic acid and glycolic acid.
Also a senior author is Lonnie Shea, adjunct professor of chemical and biological engineering at Northwestern’s McCormick School of Engineering and of obstetrics and gynecology at Feinberg, and chair of biomedical engineering at the University of Michigan.
When the allergen-loaded nanoparticle is injected into the bloodstream of mice, the immune system isn’t concerned with it because it sees the particle as innocuous debris. Then the nanoparticle and its hidden cargo are consumed by a macrophage, essentially a vacuum-cleaner cell.
“The vacuum-cleaner cell presents the allergen or antigen to the immune system in a way that says, ‘No worries, this belongs here,’” Miller said. The immune system then shuts down its attack on the allergen, and the immune system is reset to normal.
The allergen, in this case egg protein, was administered into the lungs of mice who have been pretreated to be allergic to the protein and already had antibodies in their blood against it. So when they were re-exposed to it, they responded with an allergic response like asthma. After being treated with the nanoparticle, they no longer had an allergic response to the allergen.
The approach also has a second benefit. It creates a more normal, balanced immune system by increasing the number of regulatory T cells, immune cells important for recognizing the airway allergens as normal. This method turns off the dangerous Th2 T cell that causes the allergy and expands the good, calming regulatory T cells.
The Latest on: Nanoparticles asthma allergies
via Google News
The Latest on: Nanoparticles asthma allergies
- In lab study, nanoparticle shows promising results for treating severe allergieson January 15, 2021 at 7:12 am
“Normally, asthma and anaphylaxis are treated with an ... mice that were pretreated with injections of the nanoparticle containing the entire egg protein and allergic mice pretreated with injections ...
- In lab study, nanoparticle shows promising results for treating severe allergieson January 15, 2021 at 6:25 am
For about one in 13 children in the U.S., normally harmless foodstuffs such as milk, eggs and peanuts can send the body's natural defenses into overdrive.
- In lab study, nanoparticle shows promising results for treating severe allergieson January 14, 2021 at 8:07 am
The mice were then sensitized to an egg protein in a way that would cause it to trigger asthma-like ... the liver-targeting nanoparticle containing the egg allergen generated regulatory T cells that ...
- Is your covid vaccine venue prepared to handle rare, life-threatening reactions?on January 11, 2021 at 4:24 am
immediate past president of the American Academy of Allergy, Asthma & Immunology and chairman of the department of immunology at the Cleveland Clinic. "The overwhelming likelihood is that you won ...
- Nanoparticle vaccine for COVID-19on January 8, 2021 at 10:37 am
Their vaccine, detailed in a paper published Jan. 5 in ACS Central Science, contains nanoparticles studded with the same proteins that comprise the virus's distinctive surface spikes. In addition ...
- Likely More Than One Cause for COVID-19 Vaccine Reactionson January 3, 2021 at 2:17 pm
Polyethlene glycol is a suspect in a small number of COVID-19 vaccine reactions. But experts tell Allergic Living: there are other possible culprits.
- Suspicions grow that nanoparticles in Pfizer’s COVID-19 vaccine trigger rare allergic reactionson January 3, 2021 at 4:41 am
“Until we know there is truly a PEG story, we need to be very careful in talking about that as a done deal,” says Alkis Togias, branch chief of allergy, asthma, and airway ... both contain mRNA ...
- ACAAI: Reaction to COVID-19 vaccine unlikely for those with common allergieson December 21, 2020 at 4:56 am
according to guidance released by the American College of Allergy, Asthma & Immunology (ACAAI). The ACAAI COVID-19 Vaccine Task Force issued the guidance related to the risk for an allergic ...
via Bing News